BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
- 31 August 2008
- journal article
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 41 (1), 95-99
- https://doi.org/10.1016/j.bcmd.2008.02.003
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanismsBlood, 2007
- Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomasProceedings of the National Academy of Sciences of the United States of America, 2007
- DNA damage checkpoints in mammalsMutagenesis, 2005
- BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cellsNature Immunology, 2005
- The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cellsNature, 2004
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationNature Genetics, 1997
- Germinal CentersAnnual Review of Immunology, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell LymphomaScience, 1993